Reproductive history in women with lower limb ischemia

Angiology

Volumn 55, Issue 4, 2004, Pages 373-383

  Hultgren, Rebecka ^a,b   Olofsson, Pär ^a,b   Wahlberg, Eric ^a,b  

^a Karolinska Hospital ^*

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGED; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; ORAL CONTRACEPTION; PREGNANCY; REPRODUCTION; RISK; SALPINGOOOPHORECTOMY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; CONTRACEPTIVES, ORAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; ISCHEMIA; LEG; MIDDLE AGED; REPRODUCTION; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 3142741611     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500404     Document Type: Article

References (30)

1. Colditz GA: Oral contraceptive use and mortality during 12 years of follow-up: The Nurses' Health Study. Ann Intern Med 120:821-826, 1994.
2. de Kleijn MJ, van der Schouw YT, van der Graaf Y: Reproductive history and cardiovascular disease risk in postmenopausal women: A review of the literature. Maturitas 33:7-36, 1999.
3. Palmer JR, Rosenberg L, Shapiro S: Reproductive factors and risk of myocardial infarction. Am J Epidemiol 136:408-416, 1992.
4. van der Schouw YT, van der Graaf Y, Steyerberg EW, et al: Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714-718, 1996.
5. Ness RB, Harris T, Cobb J, et al: Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med 328:1528-1533, 1993.
6. Joakimsen O, Bonaa KH, Stensland-Bugge E, et al: Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis: The Tromso Study. J Clin Epidemiol 53:525-530, 2000.
7. Hultgren R, Olofsson P, Wahlberg E: Gender differences in vascular interventions for lower limb ischaemia. Eur J Vasc Endovasc Surg 21:22-27, 2001.
8. Weiss NS: Premature menopause and aortoiliac occlusive disease. J Chronic Dis 25:133-138, 1972.
9. McKinlay SM, Brambilla DJ, Posner JG: The normal menopause transition. Maturitas 14:103-115, 1992.
10. Bergmark C, Jogestrand T, Swedenborg J: Carotid atherosclerosis in patients operated for lower extremity ischemia before the age of 50: A case control study. Ann Vasc Surg 12:430-435, 1998.
11. Cacoub P, Godeau P: Risk factors for atherosclerotic aortoiliac occlusive disease. Ann Vasc Surg 7:394-405, 1993.
12. Cronenwett JL, Davis JT Jr, Gooch JB, et al: Aortoiliac occlusive disease in women. Surgery 88:775-784, 1980.
13. Ischaemic stroke and combined oral contraceptives: Results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 348:498-505, 1996.
14. Acute myocardial infarction and combined oral contraceptives: Results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet 349:1202-1209, 1997.
15. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP: Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 22:201-210, 2002.
16. Burkman RT, Collins JA, Greene RA: Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 185(suppl 2): S13-S23, 2001.
17. Bellinger DA, Williams JK, Adams MR, et al: Oral contraceptives and hormone replacement therapy do not increase the incidence of arterial thrombosis in a nonhuman primate model. Arterioscler Thromb Vasc Biol 18:92-99, 1998.
18. John S, Jacobi J, Schlaich MP, et al: Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol 183:28-33, 2000.
19. Sidney S, Siscovick DS, Petitti DB, et al: Myocardial infarction and use of low-dose oral contraceptives: A pooled analysis of 2 US studies. Circulation 98:1058-1063, 1998.
20. Humphries KH, Westendorp IC, Bots ML, et al: Parity and carotid artery atherosclerosis in elderly women: The Rotterdam Study. Stroke 32:2259-2264, 2001.
21. Grinblatt JA: Number of pregnancies and risk of cardiovascular disease. N Engl J Med 329:1893; discussion 1894-1895, 1993.
22. Jacobsen BK, Knutsen SF, Fraser GE: Age at natural menopause and total mortality and mortality from ischemic heart disease: The Adventist Health Study. J Clin Epidemiol 52:303-307, 1999.
23. Mosca L, Collins P, Herrington DM, et al: Hormone replacement therapy and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 104:499-503, 2001.
24. Mosca L: The role of hormone replacement therapy in the prevention of postmenopausal heart disease. Arch Intern Med 160:2263-2272, 2000.
25. Mitka M: New advice for women patients about hormone therapy and the heart. JAMA 286:907, 2001.
26. Nabulsi AA, Folsom AR, Szklo M, et al: No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 94:1857-1863, 1996.
27. Hsia J, Simon JA, Lin F, et al: Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: The Heart and Estrogen/Progestin Replacement Study. Circulation 102:2228-2232, 2000.
28. Westendorp IC, in't Veld BA, Grobbee DE, et al: Hormone replacement therapy and peripheral arterial disease: The Rotterdam study. Arch Intern Med 160:2498-2502, 2000.
29. Yeh ST, Morton DJ, Barrett-Connor E: Lower extremity arterial disease in older women: The Rancho Bernardo Study. J Womens Health Gend Based Med 9:373-380, 2000.
30. Timaran CH, Stevens SL, Grandas OH, et al: Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting. J Vasc Surg 32:506-516; 516-518, 2000.